Camonagrel

CAS No. 105920-77-2

Camonagrel( —— )

Catalog No. M35990 CAS No. 105920-77-2

Camonagrel is a compound with inhibitory effects on Prostaglandin E2 (PGE2).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 922 In Stock
10MG 1226 In Stock
25MG 1853 In Stock
50MG 2437 In Stock
100MG 3283 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Camonagrel
  • Note
    Research use only, not for human use.
  • Brief Description
    Camonagrel is a compound with inhibitory effects on Prostaglandin E2 (PGE2).
  • Description
    Camonagrel is a compound that has inhibitory effects on Prostaglandin E2. Camonagrel is a potent thromboxane synthase inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Prostaglandin Receptor
  • Recptor
    Prostaglandin Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    105920-77-2
  • Formula Weight
    272.3
  • Molecular Formula
    C15H16N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(O)(=O)C1C=2C(=CC(OCCN3C=CN=C3)=CC2)CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. M A Villalobos, et al. Effects of camonagrel, a selective inhibitor of platelet thromboxane synthase, on the platelet-subendothelium interaction. Pharmacology. 2003 Sep;69(1):44-50.?
molnova catalog
related products
  • MF-766

    MF-766 is a highly potent, selective and orally active EP4 antagonist with a Ki of 0.23 nM. It behaves as a full antagonist with an IC50 of 1.4 nM (shifted to 1.8 nM in the presence of 10% HS) in the functional assay. It can be used for cancer and inflammation diseases research.

  • ASP7657

    ASP7657 (ASP-7657) is a potent, selective, orally active prostaglandin EP4 receptor antagonist with Ki values of 6.02 nM and 2.21 nM for rat and human EP4 receptors, resepctively.

  • Secoxyloganin

    Secoxyloganin possesses a hepato-protective effect. Secoxyloganin possesses antibacterial activity.